The company logo of Agilon Health
The company logo of Agilon Health

Stocks of Agilon Health - Current price, Where to buy? Chart

Basic company information Agilon Health
Detail Data
Stocks: Agilon Health
ompany Name: agilon health, inc.
Ticker: AGL
Exchange: NYSE
Outstanding stocks: 411,056,992
24-hour Volume: 4,778,479
Industry:
Sector:
Number of Employees:
Country:
City:
Address:
Price data for Agilon Health
P/E Ratio: Forward P/E EPS: Forward EPS Book value per share Market capitalization
/ -29.56 -0.48 USD -0.18 USD 1.63 USD 1,985,405,184.00 USD
Price data for Agilon Health
P/E Ratio: /
Forward P/E: -29.56
EPS: -0.48 USD
Forward EPS: -0.18
Book value per share: 1.63 USD
Market capitalization: 1,985,405,184.00 USD

Fundamental indicators for Agilon Health stocks
Indicator Data
Total Revenue: 4,316,362,752.00 USD
Net Income: -195,046,000.00 USD
Price-to-Book (P/B) Ratio: 3.27
PEG Ratio: 0.03

Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.

Predictions and price recommendations for Agilon Health stocks based on Wall Street analysts' ratings with an average target price of 8 USD per share of Agilon Health within 12 months.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation issued for Agilon Health stocks is: hold
Number of Analysts: 14
Highest Target Price: 14 USD
Lowest Target Price: 5 USD
Average Target Price: 8 USD

Note: The data is approximate. Recommendations and price forecasts for Agilon Health stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!

Dividends Value
Dividend Amount According to our data, the company Agilon Health is currently not paying dividends.
Annual Yield %: -
Ex-dividend Date: -
Average % Yield for 5 Years: -
Payout Ratio: -
Value of Last Dividend Paid: -
Date of Last Dividend: -

The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!

Where to Buy Agilon Health Stocks?

If you're interested in investing in Agilon Health stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of Agilon Health stocks through mobile apps with client support. In this table, you can compare brokers offering real Agilon Health stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.

Broker Platforms Regulation Min. Deposit Deposits / Withdrawals CopyTrader Real Stocks Website Link
Proprietary platform, social network + CopyTrader™ 100 USD Bank transfer, credit cards, Skrill, PayPal, Neteller etoro logoGo to eToro
xStation, mobile version 10 USD Credit cards, Skrill, bank transfer xtb logoGo to XTB
xStation, mobile version Proprietary platform, social network + CopyTrader™
xtb logoGo to XTB xtb logoGo to eToro
Risk warning: Trading CFDs carries a high level of risk and may not be suitable for all investors. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information about Agilon Health (AGL)

Agilon Health consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 4,316,362,752.00 USD, demonstrating its strong market position and ability to generate high revenues. Negative EBITDA of -216,090,000.00 USD may indicate challenges but also opportunities for Agilon Health to invest in future growth. Debt-to-equity ratio of 0.08 suggests that Agilon Health has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 1.61% indicates room for Agilon Health to improve cost efficiency and competitiveness. Lower profit margin of -6.08% suggests opportunities for Agilon Health to increase efficiency and reduce costs.

Indicator Value
Revenue, Debt, and Cash Flow
Company Revenue: 4,316,362,752.00 USD
EBITDA: -216,090,000.00 USD - Negative EBITDA may signal financial challenges or growth investments.
Earnings Per Share: -0.48 USD
Book Value Per Share: 1.63 USD
Total Cash: 488,343,008.00 USD
Total Cash per Share: 1.19 USD
Total Debt: 52,309,000.00 USD
Debt to Equity Ratio: 0.08
Quick Ratio: 1.46
Current Ratio: 1.52
Free Cash Flow: -70,935,376.00 USD
Operating Cash Flow: -156,199,008.00 USD
Company Margins
Gross Margins: 1.61 %
EBITDA Margins: -5.01 %
Operating Margins: -15.56 %
Profit Margins: -6.08 %
Performance
Return on Assets: -8.4 %
Return on Equity: -22.9 %
Earnings Growth (1 year): /
Revenue Growth (1 year): 53.1 %
Year-over-Year Quarterly Earnings Growth: /
Valuation
Market Capitalization: 1,985,405,184.00 USD
Enterprise Value: 1,705,050,880.00 USD
EV/Revenue: 0.395
EV/EBITDA: -7.89
Number of Shares and Short Shares
Float Shares: 303,998,682 shares
Shares Outstanding: 409,542,016 shares
Held Percent Insiders: 0.01 %
Held Percent Institutions: 110.51 %
Shares Short: 47,965,870
Shares Short Prior Month: 44,748,950
Date Short Interest: 2024-02-29
Shares Percent Shares Out: 11.71 %
Short Ratio: 8.46
Beta: 0.49
Short Percent of Float: 40.50 %
Předpokládaný počet akcií: 409,542,016

Frequently Asked Questions (FAQ)

According to our data, Agilon Health does not currently pay dividends, even in 2024.

Agilon Health shares are traded on the stock exchange NYSE under the ticker symbol: AGL. You can buy or trade them with a variety of stock brokers offering real stock trading services.

According to our data, there is a hold recommendation issued for Agilon Health shares by a total of 14 analysts. The average target price prediction is 8 USD per share.

The total number of Agilon Health shares on the exchange is 409,542,016.00, which, at the current market capitalization, values the company at 1,985,405,184.00 USD.